| 000 | 01753 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250513155326.0 | ||
| 264 | 0 | _c19990222 | |
| 008 | 199902s 0 0 eng d | ||
| 022 | _a0066-4804 | ||
| 024 | 7 |
_a10.1128/AAC.42.12.3065 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFranz, R | |
| 245 | 0 | 0 |
_aMultiple molecular mechanisms contribute to a stepwise development of fluconazole resistance in clinical Candida albicans strains. _h[electronic resource] |
| 260 |
_bAntimicrobial agents and chemotherapy _cDec 1998 |
||
| 300 |
_a3065-72 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAIDS-Related Opportunistic Infections _xdrug therapy |
| 650 | 0 | 4 | _aAlleles |
| 650 | 0 | 4 |
_aAntifungal Agents _xpharmacology |
| 650 | 0 | 4 | _aBlotting, Northern |
| 650 | 0 | 4 | _aBlotting, Southern |
| 650 | 0 | 4 |
_aCandida albicans _xdrug effects |
| 650 | 0 | 4 |
_aCandidiasis _xdrug therapy |
| 650 | 0 | 4 |
_aCytochrome P-450 Enzyme System _xgenetics |
| 650 | 0 | 4 | _aDrug Resistance, Microbial |
| 650 | 0 | 4 |
_aFluconazole _xpharmacology |
| 650 | 0 | 4 | _aGas Chromatography-Mass Spectrometry |
| 650 | 0 | 4 | _aGene Expression Regulation |
| 650 | 0 | 4 | _aGenes, MDR |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMicrobial Sensitivity Tests |
| 650 | 0 | 4 | _aNucleic Acid Hybridization |
| 650 | 0 | 4 |
_aOxidoreductases _xgenetics |
| 650 | 0 | 4 |
_aRNA, Bacterial _xgenetics |
| 650 | 0 | 4 | _aSterol 14-Demethylase |
| 700 | 1 | _aKelly, S L | |
| 700 | 1 | _aLamb, D C | |
| 700 | 1 | _aKelly, D E | |
| 700 | 1 | _aRuhnke, M | |
| 700 | 1 | _aMorschhäuser, J | |
| 773 | 0 |
_tAntimicrobial agents and chemotherapy _gvol. 42 _gno. 12 _gp. 3065-72 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1128/AAC.42.12.3065 _zAvailable from publisher's website |
| 999 |
_c9799504 _d9799504 |
||